232 related articles for article (PubMed ID: 15770046)
1. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro.
Kanai K; Asano K; Hisamitsu T; Suzaki H
Mediators Inflamm; 2004 Dec; 13(5-6):313-9. PubMed ID: 15770046
[TBL] [Abstract][Full Text] [Related]
2. Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro.
Shimizu T; Kanai K; Kyo Y; Asano K; Hisamitsu T; Suzaki H
J Pharm Pharmacol; 2006 Jan; 58(1):91-9. PubMed ID: 16393468
[TBL] [Abstract][Full Text] [Related]
3. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro.
Kanai K; Asano K; Hisamitsu T; Suzaki H
Eur Respir J; 2004 May; 23(5):671-8. PubMed ID: 15176678
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo.
Suzuki M; Asano K; Yu M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2002 Aug; 11(4):235-44. PubMed ID: 12396475
[TBL] [Abstract][Full Text] [Related]
5. Roxithromycin suppresses involucrin expression by modulation of activator protein-1 and nuclear factor-kappaB activities of keratinocytes.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Iizuka H
J Dermatol Sci; 2005 Sep; 39(3):175-82. PubMed ID: 16140218
[TBL] [Abstract][Full Text] [Related]
6. Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo.
Suzaki H; Asano K; Ohki S; Kanai K; Mizutani T; Hisamitsu T
Mediators Inflamm; 1999; 8(4-5):199-204. PubMed ID: 10704073
[TBL] [Abstract][Full Text] [Related]
7. Runt-related gene 2 is involved in the inhibition of matrix metalloproteinase-13 expression by roxithromycin in human gingival epithelial cell cultures.
Tabuchi S; Sakuta T; Oyama T; Tokuda M; Tatsuyama S; Kajihara T; Nagaoka S; Beppu M; Sugihara K; Ikebe T; Shirasuna K; Torii M
J Periodontal Res; 2009 Jun; 44(3):283-8. PubMed ID: 19453496
[TBL] [Abstract][Full Text] [Related]
8. Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.
Shimane T; Asano K; Suzuki M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2001 Dec; 10(6):323-32. PubMed ID: 11817673
[TBL] [Abstract][Full Text] [Related]
9. Roxithromycin inhibits transforming growth factor-beta production by cultured human mesangial cells.
Yamabe H; Shimada M; Kaizuka M; Nakamura M; Kumasaka R; Murakami R; Fujita T; Nakamura N; Osawa H; Okumura K
Nephrology (Carlton); 2006 Dec; 11(6):524-30. PubMed ID: 17199791
[TBL] [Abstract][Full Text] [Related]
10. Roxithromycin inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-1 expression through regulating mitogen-activated protein kinase phosphorylation and Ets-1 expression.
Oyama T; Matsushita K; Sakuta T; Tokuda M; Tatsuyama S; Nagaoka S; Torii M
J Periodontal Res; 2007 Feb; 42(1):53-61. PubMed ID: 17214640
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory action of roxithromycin on tumour necrosis factor-alpha production from mast cells in vitro.
Shimane T; Asano K; Mizutani T; Suzaki H
In Vivo; 1999; 13(6):503-6. PubMed ID: 10757045
[TBL] [Abstract][Full Text] [Related]
12. Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro.
Asano K; Kanai KI; Suzaki H
Clin Exp Allergy; 2004 Dec; 34(12):1890-8. PubMed ID: 15663564
[TBL] [Abstract][Full Text] [Related]
13. Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture.
Oyama T; Sakuta T; Matsushita K; Maruyama I; Nagaoka S; Torii M
J Periodontol; 2000 Oct; 71(10):1546-53. PubMed ID: 11063386
[TBL] [Abstract][Full Text] [Related]
14. Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF-kappaB.
Ou XM; Feng YL; Wen FQ; Wang K; Yang J; Deng ZP; Liu DS; Li YP
Respirology; 2008 Jan; 13(1):63-72. PubMed ID: 18197913
[TBL] [Abstract][Full Text] [Related]
15. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.
Urasaki Y; Nori M; Iwata S; Sasaki T; Hosono O; Kawasaki H; Tanaka H; Dang NH; Ikeda E; Morimoto C
J Rheumatol; 2005 Sep; 32(9):1765-74. PubMed ID: 16142877
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor kappaBalpha complementary DNA into immortalized human salivary gland acinar cells. Prevention of the destruction of the acinar structure in Sjögren's syndrome salivary glands.
Azuma M; Aota K; Tamatani T; Motegi K; Yamashita T; Harada K; Hayashi Y; Sato M
Arthritis Rheum; 2000 Aug; 43(8):1756-67. PubMed ID: 10943866
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation.
Miyoshi M; Miyano K; Moriyama N; Taniguchi M; Watanabe T
Eur J Neurosci; 2008 Jan; 27(2):343-51. PubMed ID: 18190523
[TBL] [Abstract][Full Text] [Related]
18. [Effect of lipopolysaccharide on expression of matrix metalloproteinase-9 in human synoviocyte from patients with rheumatoid arthritis].
Liu BH; Li YT; Shen F; Zhao DY; Cheng GF
Yao Xue Xue Bao; 2003 Apr; 38(4):245-9. PubMed ID: 12889120
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma and lipopolysaccharide stimulation increases matrix metalloproteinase-9 expression and enhances invasion activity in ras/myc-transformed serum-free mouse embryo cells.
Kidachi Y; Yamaguchi H; Umetsu H; Ryoyama K
Cell Biol Int; 2007 Dec; 31(12):1511-7. PubMed ID: 17822927
[TBL] [Abstract][Full Text] [Related]
20. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
